Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04278651 · ClinicalTrials.gov registry record · Phase 4
Early Antenatal Support for Iron Deficiency Anemia
A Phase 4 study of Pregnancy Related and Anemia, Iron Deficiency, sponsored by Thomas Jefferson University.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT04278651 is a Phase 4 study of Pregnancy Related and Anemia, Iron Deficiency that is actively recruiting participants, run by Thomas Jefferson University. The registered enrollment target is 80 participants, below the 1,962-participant average among 99 other Pregnancy Related trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04278651, a Phase 4 study of Pregnancy Related and Anemia, Iron Deficiency, is actively recruiting participants, sponsored by Thomas Jefferson University.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized, controlled multi-site trial of iron therapy in pregnancy. The purpose of this research is to see if second trimester initiation of intravenous (IV) iron therapy is better than oral iron therapy for treatment of anemia in pregnancy by improving blood count, quality of life and reducing side effects.
Conditions Studied
Interventions
- DRUG Ferumoxytol
- DRUG Ferrous Sulfate
Study Locations (1)
Pennsylvania
- Thomas Jefferson University Hospital - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2021-09-29 |
| Est. Completion | 2026-12-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04278651
The ClinicalTrials.gov registry entry for NCT04278651 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,962-participant average among 99 other Pregnancy Related trials with a reported enrollment target (96% lower). The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Pregnancy Related appearing as the primary indexed condition, and to 2 interventions - of which Ferumoxytol is the first listed.
NCT04278651 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04278651 about?
NCT04278651 is a clinical study titled "Early Antenatal Support for Iron Deficiency Anemia". This is a randomized, controlled multi-site trial of iron therapy in pregnancy. The purpose of this research is to see if second trimester initiation of intravenous (IV) iron therapy is better than oral iron therapy for treatment of anemia in pregnancy by improving blood count, quality of life and r...
What is the current status of trial NCT04278651?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 80 participants. The study started on 2021-09-29. Estimated completion is 2026-12-30.
What conditions does trial NCT04278651 study?
This clinical trial studies the following conditions: Pregnancy Related, Anemia, Iron Deficiency, Anemia of Pregnancy.
What interventions are being tested in trial NCT04278651?
The interventions under investigation include: Ferumoxytol (DRUG), Ferrous Sulfate (DRUG).
Who is sponsoring clinical trial NCT04278651?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04278651 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy Related
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Prophylactic Transfusion In Pregnant in Women With Sickle Cell Disease
RECRUITING · Phase 4
-
Perineal Massage Using A Pelvic Wand During Pregnancy
RECRUITING · Phase 4
-
Low Dose Aspirin for Preterm Preeclampsia Preventionmg/day Dose in High-risk Patients
ACTIVE NOT RECRUITING · Phase 4
-
Effects of Pregnancy-associated Hormones on THC Metabolism in Women
ACTIVE NOT RECRUITING · Phase 4
-
Misoprostol Dosing in BMI Greater Than 30
COMPLETED · Phase 4
-
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.